NI
CYTK icon

Numeric Investors’s Cytokinetics CYTK Stock Holding History

Numeric Investors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-114,894
Closed -$1.67M – 1081
2017
Q3 		$1.67M Buy
+114,894
New +$1.57M 0.01% 636
2016
Q1 		– Sell
-349,452
Closed -$3.65M – 1009
2015
Q4 		$3.65M Buy
349,452
+188,552
+117% +$1.85M 0.04% 345
2015
Q3 		$1.08M Sell
160,900
-213,208
-57% -$1.46M 0.01% 533
2015
Q2 		$2.51M Buy
374,108
+96,367
+35% +$632K 0.03% 354
2015
Q1 		$1.88M Buy
277,741
+102,589
+59% +$766K 0.02% 364
2014
Q4 		$1.4M Buy
175,152
+17,200
+11% +$73.8K 0.02% 396
2014
Q3 		$556K Buy
+157,952
New +$664K 0.01% 565
2014
Q2 		– Sell
-301,638
Closed -$2.87M – 794
2014
Q1 		$2.87M Buy
301,638
+265,622
+738% +$2.4M 0.05% 301
2013
Q4 		$234K Sell
36,016
-18,384
-34% -$121K ﹤0.01% 720
2013
Q3 		$412K Buy
+54,400
New +$583K 0.01% 612

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Numeric Investors's CYTK Position: Q4 2017 in Review

Numeric Investors sold out of Cytokinetics (CYTK) in Q4 2017, closing a stake of 114,894 shares — an estimated $1.67M sold.

Numeric Investors first reported a position in CYTK in Q3 2013 and held it in 10 quarters. The position peaked at $3.65M in Q4 2015. 134 funds tracked by Wall St. Rank hold CYTK as of Q4 2017.

  • Numeric Investors reported no remaining Cytokinetics position as of Q4 2017 after selling out during the quarter.
  • Numeric Investors sold 114,894 Cytokinetics shares in Q4 2017, an estimated $1.67M.
  • Numeric Investors first reported a position in Cytokinetics in Q3 2013 and held it in 10 quarters.
  • Numeric Investors's Cytokinetics position peaked at $3.65M in Q4 2015.
  • 134 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.